ADVL1712: A Phase I Trial of Pevonedistat Given in Combination with Fludarabine, Cytarabine, and Azacitidine in Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia


Total Award Amount

  • 15550.00
  • Direct Costs

  • 11434.00
  • Sponsor Award Id

  • Contributor

  • Aman Wadhwa   Investigator  
  • Ana Xavier   Investigator  
  • Gregory Friedman M.D.   Principal Investigator  
  • Julie Wolfson-Stockman M.D.   Investigator  
  • Matthew Kutny M.D.   Investigator